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ABSTRACT
Objective: The present work was carried out to design microemulsion gel system for transdermal delivery of the drug to minimize the side effects and 
to reduce the frequency of administration and for prolonging the duration of action.
Methods: Tramadol, an opioid analgesic drug, was mixed with various selected polymers such as sodium alginate (SA), acacia, hydroxypropyl 
methylcellulose (HPMC), and Eudragit in geometric mixing ratios. The drug, polymer, and other excipients were mixed thoroughly by trituration 
method and different formulations (F1-F8) were prepared the same quantity of all the ingredients excepting the polymers.
Results: The different formulations prepared, studied, and showed that the formulation using SA as polymeric carrier had a better effect on the 
evaluated parameters. The drug-SA formulation exhibited better drug-polymer compatibility, optimal viscosity (2750 cps), zeta potential (−26.1 Mv), 
and particle size distribution (262.8 d.nm) values. The in vitro release studies also indicated that the drug-SA formulation was of desirable release 
pattern, thus indicating that SA to be a better choice in formulating a transdermal delivery gel system.
Conclusion: Evaluated microemulsion gel formulation F2 of tramadol with polymeric carriers SA was much stable than other carriers used. Thus, it 
could be concluded that the gel formulation with SA can be taken as an ideal formulation.
Keywords: Tramadol, Microemulsion gel, Transdermal drug delivery system.
INTRODUCTION
Microemulsion is defined as an oil-in-water or water-in-oil emulsion 
producing a transparent product [1]. Techniques for enhancement 
of transdermal permeation of drugs are the use of nanoemulsion 
and microemulsion vehicles [2]. Microemulsions have received great 
attention for various applications including dermal and transdermal 
drug delivery due to ease of preparation, thermodynamic stability, 
permeation enhancement activity of their components, and a high 
solubilizing capacity for various drugs over conventional topical 
formulation vehicles [3]. Microemulsions are known to enhance 
the bioavailability of drugs through topical and systemic routes. 
Microemulsion prepared and it’s evaluated and this microemulsion 
incorporated in suitable gelling agent. Microemulsions possess a 
certain degree of elegance and are easily washed off whenever desired. 
They also have a high ability to penetrate the skin [4].
The ingredients of microemulsion could facilitate the permeation rate 
of the drug by reducing the diffusion barrier of the stratum corneum. 
However, due to low viscosity of the microemulsions, their minimal 
retention in the affected part imposes a resistance in its widespread 
use in pharmaceutical industry. It is important to prevent the drug 
loss due to draining out from the onycholytic cavity or reaching the 
systemic circulation. To circumvent these problems, the colloidal 
drug delivery carrier should be loaded in a gel base [5,6] In recent 
years, microemulsions continued to be used as solubilization capacity 
enhancers and dissolution rate improvers for poorly soluble drugs. 
The works in this area focus on two aspects: First, the effect of 
different microemulsion structures on drug solubilization capacity 
and dissolution efficiency, and second, on the physicochemical 
characterization of drug-loaded microemulsions compared to drug-free 
systems [7].
Microemulsion-based gels possess the previously mentioned 
advantages of both emulsions and gels such as better stability, better 
loading capacity, incorporation of hydrophobic drugs, and avoidance 
of the first pass effect and also have good patient acceptability. 
Advantages associated with low-surfactant microemulsion gels were 
formulated and characterized to enhance topical delivery of poorly 
soluble drugs. It was found that the choice of viscosity imparting agent 
played an important role in governing drug release from microemulsion 
gel. Microemulsion-based gels now have been used for the treatment 
of various kinds of skin disorder [8]. Topical drug delivery can be 
defined as the application of a drug containing formulation to the skin 
to directly treat the cutaneous disorders. Topical drug delivery system 
has several advantages such as ability to deliver drug more selectively 
to a specific site, avoidance of gastrointestinal incompatibility, and 
metabolic degradation associated with oral administration. Moreover, 
topical deliveries provide an increased bioavailability by avoiding the 
first pass metabolism by liver and a consistent delivery for extended 
period. In topical drug delivery system, drug diffuses out of the 
delivery system, reaches to the site of action, and gets absorbed by 
the skin [9].
The aim of this study was to develop suitable microemulsion gel 
system (without addition of gelling agent) after screening of oils, 
surfactants, and cosurfactants for transdermal delivery of tramadol 




Tramadol was received as a gift sample from Zydus Cadila Healthcare 
Ltd., Ahmedabad, Gujarat. Sodium alginate (SA), Acacia, hydroxypropyl 
methylcellulose (HPMC), Eudragit, Tween-80, sodium lauryl sulfate, 
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castor oil, and methylparaben were used as gelling agents and additives. 
All reagents and solvents used were of analytical grade.
Methods
Preparation of microemulsion gel of tramadol
Tramadol was mixed with different polymers such as SA, Acacia, HPMC, 
and Eudragit by geometric mixing. Drug, polymer, and other excipients 
were mixed thoroughly by trituration method and eight different 
formulations were prepared in which the amount of all the ingredients 
(except polymers) was kept constant including drug. The detail of 
composition of each formulation is given in Table 1.
Evaluation of tramadol microemulsion gel
Evaluated parameters for the gel formulations were appearance, pH, 
viscosity, spreadability, extrudability, zeta potential, in-vitro drug 
diffusion study.
pH [10]
The pH value conventionally represents the acidity or alkalinity of 
solution in the pharmacopoeia, standard and limit of pH have been 
provided for those pharmacopoeial substances in which pH as a measure 
of the hydrogen ion activity is important from the standpoint of stability.
The pH of gel was checked using a digital pH meter at constant 
temperature. Before this, the pH meter was calibrated using phosphate 
buffer solution of pH 3.99, 7.0, and 9.2, and then, the electrode was 
washed with dematerialized water. The electrode was then directly 
dipped into gel formulation and constant reading was noted. The 
results are mentioned in Table 2.
Viscosity [10,11]
Viscosity of the formulated microemulsion gel was determined using 
Brookfield viscometer at 25°C. The results are mentioned in Table 3.
Spreadability [10]
Spreadability of the formulations was determined by texture analyzer 
apparatus suitably modified for the study. The spreadability was 




M=Weight tied to upper glass slide
L=Length of glass slide
T=Time taken in seconds.
The results are mentioned in Table 3 and Fig. 13.
Fig. 1: Ultraviolet spectrum of pure tramadol
Fig. 2: Standard calibration curve of tramadol
Table 1: Composition of tramadol microemulsion gel with different polymer concentrations
S. No. Ingredients F1 F2 F3 F4 F5 F6 F7 F8
1 Tramadol (mg) 1000 1000 1000 1000 1000 1000 1000 1000
2 SA (mg) 1000 2000 - - - - - -
3 Acacia (mg) - - 1000 2000 - - - -
4 HPMC (mg) - - - - 1000 2000 - -
5 Eudragit (mg) - - - - - - 1000 2000
6 Tween 80 (mg) 1100 1100 1100 1100 1100 1100 1100 1100
7 Sodium lauryl sulfate (mg) 150 150 150 150 150 150 150 150
8 Castor oil (mg) 1900 1900 1900 1900 1900 1900 1900 1900
9 Methylparaben (mg) 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5
10 Distilled water (qs) (ml) 100 100 100 100 100 100 100 100
SA: Sodium alginate, HPMC: Hydroxypropyl methylcellulose
Table 2: Physical evaluations of gel formulations
Formulations Appearance Feel on application Gelling pH
F1 Off white color Smooth + + + 6.99
F2 Off white color Smooth + + + + 7.42
F3 Off white color Smooth  + + 6.83
F4 Off white color Smooth + + + 6.91
F5 Off white color Smooth + + 6.89
F6 Off white color Smooth + + + 6.95
F7 Off white color Smooth + + 6.80
F8 Off white color Smooth + + + 6.92
Grades were allotted as + + + + Excellent, + + + Good, + + Fair, and +Poor
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Assay [10-14]
An amount of the formulated gel equivalent to 5 mg tramadol was weighed 
and immersed in a 100 ml volumetric flask containing 80 ml of phosphate 
buffer (pH 7.4). The flask was stoppered and placed in a mechanical 
shaking water bath set at 37°C for 2 h to allow for complete dissolution 
of the drug and made up to volume with phosphate buffer. 20 ml aliquot 
of this solution was withdrawn and placed in 100 ml volumetric flask and 
the volume made up using distilled water. The ultraviolet (UV) absorbance 
of the solution was read at 272 nm using phosphate buffer (pH 7.4) as 
the blank. The tramadol content, in µg/ml, was determined from the 
absorbance value obtained and read against a standard calibration 
curve. This content was then calculated as a percentage of the expected 
concentration of tramadol. The results are mentioned in Table 4.
Zeta potential
Zeta potential was measured using Zetasizer Nano ZS (Malvern 
Instruments, Worcestershire, UK). The measurement was performed at 
25°C. The results are mentioned in Table 4 and Fig. 14.
In vitro drug diffusion study [10-14]
Arrangement of assembly
• The in vitro release of tramadol gel from the prepared formulation 
through using double end open cylinder and is ready to diffuse from 
the cellophane membrane.
• The release medium used was phosphate buffer pH 7.4. Cellulose 
acetate paper was soaked for 2 h in phosphate buffer.
Fig. 3: Infrared spectrum of tramadol
Fig. 4: Infrared spectrum of sodium alginate
Table 3: Viscosity and spreadability determination
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• 2.5 g of the formulated gel (equivalent to 200 mg tramadol) were 
weighed onto separate open end glass tube.
• The glass tube was then suspended in 250 ml phosphate buffer pH 7.4 
solution maintained at 37±0.5°C. The paddles were rotated at 75 rpm 
and aliquots of 1 ml withdrawn at 10, 20, 30, 40, and 50 min and 1, 
2, and 4 h.
• Aliquots were replaced by equal volumes of the phosphate buffer 
solution. The absorbance of the aliquots was measured at 272 nm.
• The cumulative percentage drug release was calculated based on 
the concentrations obtained for the various gels overtime as a 
function of the loading doses (equivalent weight of tramadol in 1 g 
samples of the gel).
The results are mentioned in Table 5.
Fig. 5: Infrared spectrum of tramadol + sodium alginate
Fig. 6: Infrared spectrum of gum acacia
Table 4: Physicochemical evaluation of optimized gel 
formulation (F2)
S. No. Evaluation parameters Results
1 Extrudability 268.464 g
2 Assay 99.7%
3 Zeta potential −26.1 Mv
4 Size distribution 262.8 (d.nm)
Table 5: In vitro diffusion study of tramadol gel
Time F2 F4 F6 F8
10 min 16.74 11.24 12.36 9.29
20 min 25.26 20.82 23.12 19.43
30 min 36.28 28.12 37.28 31.38
40 min 47.86 38.48 41.22 43.92
50 min 53.18 49.16 63.12 52.84
1 h 64.26 63.28 75.64 65.46
2 h 78.97 74.81 81.27 73.89
4 h 89.17 79.72 84.13 80.74
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Fig. 7: Infrared spectrum of tramadol + gum acacia
Fig. 8: Infrared spectrum of hydroxypropyl methylcellulose
Table 6: Stability parameter of selected formulation F2
Parameters Initial After 1 month 
40/75 (°C/RH)







Viscosity 2750 cps 2712 cps
Spreadability 124. 699 g 123.579 g
Extrudability 268. 464 g 270.347 g













Stability testing of the optimized formulation was performed to predict 
the quality of drug substance or drug product variation with time under 
the influence of changing environmental factors such as temperature, 
humidity and light, enabling recommended storage condition, retest 
periods, and shelf lives. To avoid this undesirable delay, the principles 
of accelerated stability studies are adopted. The results are mentioned 
in Table 6.
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Fig. 10: Infrared spectrum of Eudragit
Fig. 9: Infrared spectrum of tramadol + hydroxypropyl methylcellulose
RESULTS AND DISCUSSION
The present study was carried out to develop gel tramadol to enhance 
absorption and bioavailability of the drug.
Physicochemical properties
Tramadol is a white crystalline powder with bitter taste, sparingly 
soluble in water (1151 mg/L at 25°C) and freely soluble in alcohol and 
acid. Tramadol exhibits crystal polymorphism. Tramadol melting point 
was determined to be 180–181°C which was in compliance with the 
official value.
UV spectroscopic study
Tramadol in 0.1 N phosphate buffer solutions showed maximum 
absorbance (λmax) of 272 nm and calibration curve exhibiting good 
linearity that obeys Beer–Lambert’s law. The Beer–Lambert’s 
concentration range was studied with a concentration range of 
1–10 µg/ml at 272 nm showed coefficient of correlation value of 0.994. 
The slope and intercept values were 0.026 and 0.009, respectively. The 
data are shown in Table 7 and Figs. 1 and 2.
Drug and excipient interaction studies
Drug-excipient interaction of tramadol and the polymers (SA, Acacia, 
Eudragit, and HPMC) studied in drug-excipient physical mixture 
showed no significant changes in the peak (at 163.88, 163.01, 
and 163.33°C, respectively) of the drug in these mixtures, which 
refers that there was no interaction. The results are mentioned in 
Figs. 3-12.
The nitroglycerin (NTG)-magnesium stearate mixture was subjected 
to infrared (IR) studies and its spectrum was compared with the IR 
spectra of NTG. Characteristic bands of NTG were observed at 1647 
cm–1 (–C=O), 1713 cm–1 (–COOH), 2862–3096 cm–1 (–CH2-cycloalkane), 
and 3296 cm–1 (–NH stretching). However, the IR spectrum of the NTG-
magnesium stearate mixture showed the respective characteristic 
bands of NTG at 1647, 1712, 2850–2953 (–CH2-cycloalkane), and 3300 
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Fig. 11: Infrared spectrum of tramadol + Eudragit
Fig. 12: Infrared spectrum of optimized formulation of F2
Fig. 13: Graph of spreadability
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Fig. 14: Graph of zeta potential
Fig. 15: Graph of size distribution
cm–1. The results confirmed that there was no chemical interaction 
between NTG and magnesium stearate.
Evaluation of microemulsion gel formulations F1-F8
Different methods were selected for the preparation of gel. These 
depend on the nature of polymer used (Discussed in methodology). 
Different concentrations of polymers were tried for the formulation of 
tramadol gel. The concentration of SA, Acacia, HPMC, and Eudragit was 
taken 1 g and 2 g.
Physical evaluation of gel formulations
Evaluations such as physical appearance, texture of the gel, uniformity of 
the gel, and pH values studied results are mentioned in Table 2 and Fig. 15.
Physicochemical evaluation
Evaluations of the physicochemical properties for the selected 
formulation (F2, F4, F6, and F8) and optimized formulation (F2) are 
given in Tables 3 and 4.
Cumulative percentage drug release of microemulsion gel 
formulations
The cumulative percentage drug release from the selected formulations 
(F2, F4, F6, and F8) was studied exhibited the results as given in Table 5.
Stability study
Stability study was carried out for the optimized formulation according 
to ICH guidelines at 40°C/75% RH for 1 month. The results showed that 
there was no significant change in physical and chemical parameter of 
the gel; hence, the formulation (F2) was found to be stable (Table 6).
CONCLUSION
The present study was aimed to formulate and evaluate the 
microemulsion gel formulations of tramadol using various polymeric 
carriers. Based on the preformulation studies, further course of 
formulation and evaluation of optimized formulation of the drug were 
carried out with using different polymers and selected excipients.
The microemulsion gels were evaluated for physical characterizations 
(pH, appearance, spreadability, extrudability, and viscosity) and in vitro 
diffusion and optimized formulation suitable for better delivery of the 
drug was identified and studied further. The initial evaluation studies 
were indicative that the F2 formulation exhibited optimal results 
for the study parameters evaluated and showed to comply with the 
pharmacopoeial standard references. Further, the data from physical, 
physiochemical, and in vitro diffusion studies for the microemulsion 
gel formulation F2 directed in concluding that the F2 formulation has 
a better delivery capacity and can also be a promising dosage form 
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for topical route of administration of the tramadol. Stability study 
was conducted of F2 stored at 40°C/75% RH for 1 month. Gels were 
evaluated for appearance, feel on application, pH, viscosity, assay, and 
in vitro diffusion profile after 1 month. It concluded that formulation 
F2 was stable. From the above results, it concluded that tramadol gel 
formulation containing SA 3% can be taken as an ideal formulation.
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